Literature DB >> 19545493

Vaccination for the prevention of pneumococcal meningitis.

Allan R Tunkel.   

Abstract

Entities:  

Year:  2009        PMID： 19545493     DOI： 10.1007/s11908-009-0038-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  10 in total

1.  Practice guidelines for the management of bacterial meningitis.

Authors:  Allan R Tunkel; Barry J Hartman; Sheldon L Kaplan; Bruce A Kaufman; Karen L Roos; W Michael Scheld; Richard J Whitley
Journal:  Clin Infect Dis       Date:  2004-10-06       Impact factor: 9.079

2.  Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.

Authors:  Michael R Jacobs; Caryn E Good; Saralee Bajaksouzian; Anne R Windau
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

3.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Authors:  S Black; H Shinefield; B Fireman; E Lewis; P Ray; J R Hansen; L Elvin; K M Ensor; J Hackell; G Siber; F Malinoski; D Madore; I Chang; R Kohberger; W Watson; R Austrian; K Edwards
Journal:  Pediatr Infect Dis J       Date:  2000-03       Impact factor: 2.129

4.  Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.

Authors:  Katherine A Poehling; Thomas R Talbot; Marie R Griffin; Allen S Craig; Cynthia G Whitney; Elizabeth Zell; Catherine A Lexau; Ann R Thomas; Lee H Harrison; Arthur L Reingold; James L Hadler; Monica M Farley; Bridget J Anderson; William Schaffner
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

5.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

6.  Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.

Authors:  Carmen Muñoz-Almagro; Iolanda Jordan; Amadeo Gene; Cristina Latorre; Juan J Garcia-Garcia; Roman Pallares
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

7.  Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine.

Authors:  Juan Casado-Flores; Carlos Rodrigo; Javier Arístegui; Jose María Martínón; Asunción Fenoll; Cristina Mendez
Journal:  Pediatr Infect Dis J       Date:  2008-11       Impact factor: 2.129

8.  Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

Authors:  Sheldon L Kaplan; Edward O Mason; Ellen R Wald; Gordon E Schutze; John S Bradley; Tina Q Tan; Jill A Hoffman; Laurence B Givner; Ram Yogev; William J Barson
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

9.  Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007.

Authors:  Carmen Ardanuy; Fe Tubau; Román Pallares; Laura Calatayud; María Angeles Domínguez; Dora Rolo; Inmaculada Grau; Rogelio Martín; Josefina Liñares
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

10.  Changing epidemiology of bacterial meningitis.

Authors:  Mark Alain Dery; Rodrigo Hasbun
Journal:  Curr Infect Dis Rep       Date:  2007-07       Impact factor: 3.725
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.